Krebs Biochemicals & Industries Limited
KREBSBIO.BO
Price:
$70.5
Market Cap:
$1.50B
Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. The...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2004-01-02
Stock Exchange
BSE
Ticker
KREBSBIO.BO
PE Ratio
[-5.53]
ROE
[18.94%]
Current Ratio
[0.09]
Dividend Yield
[0%]
Enterprise Value
[3.69B]
Dividend History
The ROE as of December 2025 (TTM) for Krebs Biochemicals & Industries Limited (KREBSBIO.BO) is 18.94%
According to Krebs Biochemicals & Industries Limited’s latest financial reports and current stock price. The company's current ROE is 18.94%. This represents a change of 295.84% compared to the average of 4.78% of the last 4 quarters.
Krebs Biochemicals & Industries Limited (KREBSBIO.BO) Historical ROE (quarterly & annually)
How has KREBSBIO.BO ROE performed in the past?
The mean historical ROE of Krebs Biochemicals & Industries Limited over the last ten years is -67.08%. The current 18.94% ROE has changed -128.23% with respect to the historical average. Over the past ten years (40 quarters), KREBSBIO.BO's ROE was at its highest in in the June 2019 quarter at 53.10%. The ROE was at its lowest in in the June 2017 quarter at -401.76%.
Average
-67.08%
Median
42.06%
Minimum
-1086.70%
Maximum
140.05%
Krebs Biochemicals & Industries Limited (KREBSBIO.BO) ROE by Quarter and Year
Discovering the peaks and valleys of Krebs Biochemicals & Industries Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 766.51%
Maximum Annual ROE = 140.05%
Minimum Annual Increase = -109.23%
Minimum Annual ROE = -1086.70%
| Year | ROE | Change |
|---|---|---|
| 2025 | 18.42% | 11.32% |
| 2024 | 16.55% | -33.34% |
| 2023 | 24.83% | -58.13% |
| 2022 | 59.30% | -10.65% |
| 2021 | 66.36% | -42.55% |
| 2020 | 115.51% | -17.52% |
| 2019 | 140.05% | 39.69% |
| 2018 | 100.26% | -109.23% |
| 2017 | -1086.70% | 766.51% |
| 2016 | -125.41% | 513.31% |
Krebs Biochemicals & Industries Limited (KREBSBIO.BO) Average ROE
How has KREBSBIO.BO ROE performed in the past?
The current ROE of Krebs Biochemicals & Industries Limited (KREBSBIO.BO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
19.93%
5-year avg
37.09%
10-year avg
-67.08%
Krebs Biochemicals & Industries Limited (KREBSBIO.BO) ROE vs. Peers
How is KREBSBIO.BO’s ROE compared to its peers?
Krebs Biochemicals & Industries Limited’s ROE is less than Achyut Healthcare Limited (1.36%), less than Bal Pharma Limited (9.51%), less than Par Drugs and Chemicals Limited (14.46%), less than Bal Pharma Limited (9.51%), less than Alpa Laboratories Limited (15.61%), greater than Mangalam Drugs & Organics Limited (-6.58%), less than Alpa Laboratories Limited (15.61%), greater than Mangalam Drugs & Organics Limited (-6.58%), less than Smruthi Organics Limited (4.86%), less than Lactose (India) Limited (7.98%),
| Company | ROE | Market cap |
|---|---|---|
| 1.36% | $1.29B | |
| 9.51% | $1.14B | |
| 14.46% | $1.29B | |
| 9.51% | $1.15B | |
| 15.61% | $1.70B | |
| -6.58% | $394.44M | |
| 15.61% | $1.71B | |
| -6.58% | $394.76M | |
| 4.86% | $1.37B | |
| 7.98% | $1.51B |
Build a custom stock screener for Krebs Biochemicals & Industries Limited (KREBSBIO.BO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Krebs Biochemicals & Industries Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Krebs Biochemicals & Industries Limited (KREBSBIO.BO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Krebs Biochemicals & Industries Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Krebs Biochemicals & Industries Limited's ROE?
How is the ROE calculated for Krebs Biochemicals & Industries Limited (KREBSBIO.BO)?
What is the highest ROE for Krebs Biochemicals & Industries Limited (KREBSBIO.BO)?
What is the 3-year average ROE for Krebs Biochemicals & Industries Limited (KREBSBIO.BO)?
What is the 5-year average ROE for Krebs Biochemicals & Industries Limited (KREBSBIO.BO)?
How does the current ROE for Krebs Biochemicals & Industries Limited (KREBSBIO.BO) compare to its historical average?